nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—SERPINA6—blood plasma—schizophrenia	0.0484	0.113	CbGeAlD
Fluocinonide—NR3C1—urine—schizophrenia	0.0406	0.0948	CbGeAlD
Fluocinonide—SMO—midbrain—schizophrenia	0.0318	0.0742	CbGeAlD
Fluocinonide—SMO—endocrine gland—schizophrenia	0.0279	0.0652	CbGeAlD
Fluocinonide—SMO—nervous system—schizophrenia	0.0262	0.061	CbGeAlD
Fluocinonide—SMO—central nervous system—schizophrenia	0.0252	0.0588	CbGeAlD
Fluocinonide—SMO—cerebellum—schizophrenia	0.0246	0.0574	CbGeAlD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—FZD3—schizophrenia	0.0235	0.0432	CbGpPWpGaD
Fluocinonide—NR3C1—blood plasma—schizophrenia	0.0212	0.0495	CbGeAlD
Fluocinonide—SMO—brain—schizophrenia	0.02	0.0467	CbGeAlD
Fluocinonide—SERPINA6—blood—schizophrenia	0.0177	0.0414	CbGeAlD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—schizophrenia	0.0157	0.0289	CbGpPWpGaD
Fluocinonide—SERPINA6—endocrine gland—schizophrenia	0.0154	0.0359	CbGeAlD
Fluocinonide—SERPINA6—nervous system—schizophrenia	0.0144	0.0336	CbGeAlD
Fluocinonide—SERPINA6—central nervous system—schizophrenia	0.0139	0.0324	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—schizophrenia	0.0136	0.0316	CbGeAlD
Fluocinonide—SMO—GPCRs, Other—ADORA2A—schizophrenia	0.0124	0.0228	CbGpPWpGaD
Fluocinonide—NR3C1—forebrain—schizophrenia	0.0116	0.0271	CbGeAlD
Fluocinonide—NR3C1—Nuclear Receptors—NR4A2—schizophrenia	0.0115	0.0212	CbGpPWpGaD
Fluocinonide—SERPINA6—brain—schizophrenia	0.011	0.0257	CbGeAlD
Fluocinonide—NR3C1—telencephalon—schizophrenia	0.0107	0.0249	CbGeAlD
Fluocinonide—SMO—GPCRs, Other—DRD3—schizophrenia	0.0101	0.0185	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NOS1AP—schizophrenia	0.01	0.0185	CbGpPWpGaD
Fluocinonide—Fluocinolone Acetonide—PLA2G4A—schizophrenia	0.00987	0.35	CrCbGaD
Fluocinonide—SMO—GPCRs, Other—DRD4—schizophrenia	0.00977	0.018	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—GSK3B—schizophrenia	0.00953	0.0175	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—CNR1—schizophrenia	0.00933	0.0172	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—HTR7—schizophrenia	0.0091	0.0168	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—NR4A2—schizophrenia	0.00909	0.0167	CbGpPWpGaD
Fluocinonide—NR3C1—gonad—schizophrenia	0.00892	0.0208	CbGeAlD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—GSK3B—schizophrenia	0.00856	0.0158	CbGpPWpGaD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—schizophrenia	0.00805	0.0148	CbGpPWpGaD
Fluocinonide—NR3C1—blood—schizophrenia	0.00777	0.0181	CbGeAlD
Fluocinonide—NR3C1—midbrain—schizophrenia	0.00767	0.0179	CbGeAlD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SMARCA2—schizophrenia	0.00749	0.0138	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CLOCK—schizophrenia	0.00692	0.0127	CbGpPWpGaD
Fluocinonide—Fluticasone Propionate—PLA2G4A—schizophrenia	0.00675	0.239	CrCbGaD
Fluocinonide—NR3C1—endocrine gland—schizophrenia	0.00674	0.0157	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—FZD3—schizophrenia	0.00641	0.0118	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—HTR2A—schizophrenia	0.00637	0.0117	CbGpPWpGaD
Fluocinonide—NR3C1—nervous system—schizophrenia	0.00631	0.0147	CbGeAlD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—AKT1—schizophrenia	0.00613	0.0113	CbGpPWpGaD
Fluocinonide—NR3C1—central nervous system—schizophrenia	0.00607	0.0142	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—TAAR6—schizophrenia	0.00603	0.0111	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GRM2—schizophrenia	0.00603	0.0111	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—NTS—schizophrenia	0.006	0.011	CbGpPWpGaD
Fluocinonide—NR3C1—cerebellum—schizophrenia	0.00594	0.0139	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—NTS—schizophrenia	0.00545	0.01	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GRM3—schizophrenia	0.00513	0.00944	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—CLOCK—schizophrenia	0.00504	0.00928	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR6—schizophrenia	0.00503	0.00926	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog 'off' state—GSK3B—schizophrenia	0.00484	0.0089	CbGpPWpGaD
Fluocinonide—NR3C1—brain—schizophrenia	0.00482	0.0113	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—CHRM1—schizophrenia	0.00445	0.00818	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—GSK3B—schizophrenia	0.00432	0.00794	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.00417	0.00767	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GRM5—schizophrenia	0.00413	0.00761	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.0041	0.00755	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.00398	0.00733	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DGKI—schizophrenia	0.00387	0.00713	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCK—schizophrenia	0.00378	0.00696	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.00371	0.00684	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CYP26B1—schizophrenia	0.00365	0.00673	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCKAR—schizophrenia	0.00362	0.00667	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—schizophrenia	0.00356	0.00655	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PPP1R1B—schizophrenia	0.00354	0.00652	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—ADORA2A—schizophrenia	0.00351	0.00647	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—AKT1—schizophrenia	0.0034	0.00627	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—FZD3—schizophrenia	0.00329	0.00606	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—NPY—schizophrenia	0.00328	0.00604	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—OXT—schizophrenia	0.00317	0.00583	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR1B—schizophrenia	0.00317	0.00583	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.00313	0.00575	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PPP3CC—schizophrenia	0.00309	0.0057	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TAAR6—schizophrenia	0.00309	0.0057	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM2—schizophrenia	0.00309	0.0057	CbGpPWpGaD
Fluocinonide—Clobetasol propionate—CYP1A2—schizophrenia	0.00309	0.109	CrCbGaD
Fluocinonide—SMO—GPCR ligand binding—HTR1A—schizophrenia	0.00305	0.00561	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—NPS—schizophrenia	0.003	0.00553	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2C—schizophrenia	0.00294	0.00542	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD1—schizophrenia	0.00294	0.00542	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TH—schizophrenia	0.00289	0.00531	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—ESR1—schizophrenia	0.00287	0.00529	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—schizophrenia	0.00287	0.00529	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NGEF—schizophrenia	0.00286	0.00527	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD3—schizophrenia	0.00285	0.00525	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.00284	0.00523	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.00282	0.00518	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.00282	0.00518	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NTS—schizophrenia	0.0028	0.00515	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD4—schizophrenia	0.00277	0.0051	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—MEF2C—schizophrenia	0.00265	0.00487	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—schizophrenia	0.00265	0.00487	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CNR1—schizophrenia	0.00264	0.00487	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM3—schizophrenia	0.00263	0.00484	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RGS4—schizophrenia	0.00263	0.00484	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR6—schizophrenia	0.00258	0.00475	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR7—schizophrenia	0.00258	0.00475	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD2—schizophrenia	0.00258	0.00475	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—PRL—schizophrenia	0.00236	0.00434	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.00234	0.00431	CbGpPWpGaD
Fluocinonide—Ciclesonide—CYP2D6—schizophrenia	0.00232	0.0821	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—DGKI—schizophrenia	0.00229	0.00421	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CHRM1—schizophrenia	0.00228	0.0042	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—schizophrenia	0.00227	0.00418	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL10—schizophrenia	0.00224	0.00413	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL3RA—schizophrenia	0.00222	0.00409	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00221	0.00407	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—schizophrenia	0.00216	0.00397	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.00213	0.00393	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GRM5—schizophrenia	0.00212	0.0039	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PPP1R1B—schizophrenia	0.00209	0.00385	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00202	0.00372	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—GSK3B—schizophrenia	0.002	0.00368	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.002	0.00368	CbGpPWpGaD
Fluocinonide—Fluticasone furoate—ABCB1—schizophrenia	0.00199	0.0705	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—FZD3—schizophrenia	0.00194	0.00358	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.00194	0.00358	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCK—schizophrenia	0.00194	0.00357	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PDE4B—schizophrenia	0.00189	0.00348	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.00187	0.00343	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCKAR—schizophrenia	0.00186	0.00342	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00183	0.00338	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PPP3CC—schizophrenia	0.00183	0.00337	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TAAR6—schizophrenia	0.00183	0.00337	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FES—schizophrenia	0.00183	0.00337	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM2—schizophrenia	0.00183	0.00337	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2A—schizophrenia	0.00181	0.00333	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—ADORA2A—schizophrenia	0.0018	0.00332	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00177	0.00325	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—ESR1—schizophrenia	0.00176	0.00325	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—schizophrenia	0.00175	0.00323	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.00171	0.00314	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.00171	0.00314	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NGEF—schizophrenia	0.00169	0.00311	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPY—schizophrenia	0.00168	0.0031	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00166	0.00305	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTS—schizophrenia	0.00165	0.00304	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OXT—schizophrenia	0.00163	0.00299	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR1B—schizophrenia	0.00163	0.00299	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—FOS—schizophrenia	0.00159	0.00292	CbGpPWpGaD
Fluocinonide—Methylprednisolone—ABCB1—schizophrenia	0.00159	0.0562	CrCbGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NR4A2—schizophrenia	0.00157	0.00289	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—schizophrenia	0.00157	0.00289	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR1A—schizophrenia	0.00156	0.00288	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RGS4—schizophrenia	0.00155	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RTN4—schizophrenia	0.00155	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM3—schizophrenia	0.00155	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPS—schizophrenia	0.00154	0.00284	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR6—schizophrenia	0.00153	0.00281	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TH—schizophrenia	0.00152	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.00151	0.00279	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2C—schizophrenia	0.00151	0.00278	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD1—schizophrenia	0.00151	0.00278	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAG—schizophrenia	0.00147	0.00271	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD3—schizophrenia	0.00146	0.00269	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD4—schizophrenia	0.00142	0.00262	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.00141	0.0026	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—schizophrenia	0.00141	0.00259	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—schizophrenia	0.0014	0.00258	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CNR1—schizophrenia	0.00136	0.0025	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CHRM1—schizophrenia	0.00135	0.00248	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	0.00134	0.00246	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—MEF2C—schizophrenia	0.00133	0.00245	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD2—schizophrenia	0.00132	0.00244	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR7—schizophrenia	0.00132	0.00244	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—TSNAX—schizophrenia	0.00132	0.00242	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—EP300—schizophrenia	0.00131	0.00242	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL3RA—schizophrenia	0.00131	0.00242	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.00128	0.00236	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TLE1—schizophrenia	0.00128	0.00236	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRG3—schizophrenia	0.00128	0.00236	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—EP300—schizophrenia	0.00128	0.00235	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GFAP—schizophrenia	0.00127	0.00233	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRM5—schizophrenia	0.00125	0.00231	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.00124	0.00228	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TLE3—schizophrenia	0.00121	0.00223	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00118	0.00218	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.00115	0.00212	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCK—schizophrenia	0.00115	0.00211	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.00113	0.00208	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDE4B—schizophrenia	0.00112	0.00206	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.00111	0.00205	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCKAR—schizophrenia	0.0011	0.00202	CbGpPWpGaD
Fluocinonide—Betamethasone—ABCB1—schizophrenia	0.0011	0.0388	CrCbGaD
Fluocinonide—NR3C1—Gene Expression—LSM1—schizophrenia	0.00107	0.00197	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADORA2A—schizophrenia	0.00107	0.00196	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—EP300—schizophrenia	0.00105	0.00194	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PLA2G4A—schizophrenia	0.00105	0.00193	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.00105	0.00193	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGA—schizophrenia	0.00102	0.00188	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPY—schizophrenia	0.000995	0.00183	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH4—schizophrenia	0.000995	0.00183	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ATP2A2—schizophrenia	0.000995	0.00183	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR1B—schizophrenia	0.00096	0.00177	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OXT—schizophrenia	0.00096	0.00177	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.000936	0.00172	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—schizophrenia	0.000927	0.00171	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2A—schizophrenia	0.000927	0.00171	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR1A—schizophrenia	0.000924	0.0017	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—schizophrenia	0.000922	0.0017	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPS—schizophrenia	0.00091	0.00168	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2C—schizophrenia	0.000893	0.00164	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD1—schizophrenia	0.000893	0.00164	CbGpPWpGaD
Fluocinonide—Dexamethasone—CYP2D6—schizophrenia	0.000893	0.0316	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—NTRK2—schizophrenia	0.000868	0.0016	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD3—schizophrenia	0.000865	0.00159	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD4—schizophrenia	0.000839	0.00155	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH4—schizophrenia	0.000803	0.00148	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR1—schizophrenia	0.000801	0.00148	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD2—schizophrenia	0.000782	0.00144	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR7—schizophrenia	0.000782	0.00144	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NR4A2—schizophrenia	0.000756	0.00139	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—schizophrenia	0.000753	0.00139	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRL—schizophrenia	0.000738	0.00136	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SMG6—schizophrenia	0.000691	0.00127	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—S100B—schizophrenia	0.000688	0.00127	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—schizophrenia	0.000664	0.00122	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB4—schizophrenia	0.000658	0.00121	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCB1—schizophrenia	0.000637	0.0226	CrCbGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.00062	0.00114	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PLA2G4A—schizophrenia	0.000619	0.00114	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRG1—schizophrenia	0.000607	0.00112	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MEF2C—schizophrenia	0.000602	0.00111	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—YWHAZ—schizophrenia	0.000582	0.00107	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ERBB3—schizophrenia	0.000569	0.00105	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	0.000566	0.00104	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—schizophrenia	0.00056	0.00103	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—EP300—schizophrenia	0.000554	0.00102	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2A—schizophrenia	0.000548	0.00101	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—schizophrenia	0.000521	0.000958	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—schizophrenia	0.000509	0.000937	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOA1—schizophrenia	0.000503	0.000926	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ESR1—schizophrenia	0.000486	0.000895	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—schizophrenia	0.00045	0.000828	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GSK3B—schizophrenia	0.000441	0.000812	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR1—schizophrenia	0.000392	0.000722	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH4—schizophrenia	0.000387	0.000712	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT1—schizophrenia	0.000347	0.000639	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HSPA8—schizophrenia	0.000342	0.00063	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HSPA1A—schizophrenia	0.000311	0.000573	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—schizophrenia	0.000297	0.000546	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EP300—schizophrenia	0.00029	0.000534	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—YWHAZ—schizophrenia	0.000226	0.000416	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—schizophrenia	0.000208	0.000382	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR1—schizophrenia	0.000189	0.000348	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—schizophrenia	0.000175	0.000323	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—schizophrenia	6.81e-05	0.000125	CbGpPWpGaD
